Requires the Washington state review board to establish a diversity in clinical trials program to encourage participation in clinical trials of drugs and medical devices by persons who are members of demographic groups that are underrepresented in clinical trials.

Requires state entities that conduct clinical trials of drugs or medical devices, including the University of Washington, to adopt a policy concerning the identification and recruitment of persons who are members of underrepresented demographic groups to participate in clinical trials.